2nd EurocanPlatform translational research course is good for networking

Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015

Reasons to attend the EurocanPlatform translational research course 2015

Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015

Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015

Should young adults with acute lymphocytic leukaemia receive paediatric treatment protocols?

Dr Wendy Stock - University of Chicago, Chicago, USA
Should young adults with acute lymphocytic leukaemia receive paediatric treatment protocols? ( Dr Wendy Stock - University of Chicago, Chicago, USA )
8 Dec 2014

Children with rare leukaemia have better-than-expected outcomes after tailored treatment

Dr Brent Wood - Seattle Children's Hospital, Seattle, USA
Children with rare leukaemia have better-than-expected outcomes after tailored treatment ( Dr Brent Wood - Seattle Children's Hospital, Seattle, USA )
7 Dec 2014

Immunology highlights from ASH 2014

Dr Catherine Bollard - George Washington University, Washington, USA
Immunology highlights from ASH 2014 ( Dr Catherine Bollard - George Washington University, Washington, USA )
7 Dec 2014

Comment: T cell therapy for children with aggressive leukaemia

Dr Catherine Bollard - George Washington University, Washington, USA
Comment: T cell therapy for children with aggressive leukaemia ( Dr Catherine Bollard - George Washington University, Washington, USA )
7 Dec 2014

Children with aggressive leukaemia experiencing remission with T cell therapy

Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA
Children with aggressive leukaemia experiencing remission with T cell therapy ( Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA )
7 Dec 2014

Potential role of blood testing for microRNA profiles in paediatric cancers

Dr Matthew Murray - University of Cambridge, Cambridge, UK
Potential role of blood testing for microRNA profiles in paediatric cancers ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )
11 Nov 2014